Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03313895
Previous Study | Return to List | Next Study

The ACT Trial: Effects of Combined Aerobic Exercise and Cognitive Training in MCI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03313895
Recruitment Status : Recruiting
First Posted : October 18, 2017
Last Update Posted : October 29, 2019
Sponsor:
Collaborators:
University of Rochester
Mayo Clinic
University of St Thomas
Information provided by (Responsible Party):
University of Minnesota

Brief Summary:
This multi-site clinical trial occurs at the University of Minnesota and University of Rochester. It tests the efficacy and additive/synergistic effects of an ACT intervention on cognition and relevant mechanisms (aerobic fitness, Alzheimer's disease [AD] signature cortical thickness, and default mode network [DMN]) in older adults with amnestic MCI (aMCI).

Condition or disease Intervention/treatment Phase
Mild Cognitive Impairment Behavioral: ACT Behavioral: Cycling Only Behavioral: Cognitive Training Only Behavioral: Stretching and Mental Stimulating Activities Not Applicable

Detailed Description:
Because almost all drug trials for Alzheimer's disease (AD) have failed, developing non-pharmacological interventions with strong potential to prevent or delay the onset of AD in high-risk populations (e.g., those with mild cognitive impairment [MCI]) is critically important. Aerobic exercise and cognitive training are 2 promising interventions for preventing AD. Aerobic exercise increases aerobic fitness, which in turn improves brain structure and function, while cognitive training improves selective neural function intensively. Hence, combined Aerobic exercise and Cognitive Training (ACT) may very well have an additive or synergistic effect on cognition by complementary strengthening of different neural functions. Few studies have tested ACT's effects, and those studies have reported discrepant findings, largely due to varying ACT programs. The purpose of this single-blinded, 2×2 factorial Phase II randomized controlled trial (RCT) is to test the efficacy and additive/synergistic effects of a 6-month combined cycling and speed of processing (SOP) training intervention on cognition and relevant mechanisms (aerobic fitness, AD signature cortical thickness, and functional connectivity in the default mode network [DMN]) in older adults with amnestic MCI (aMCI).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 128 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training (ACT) in MCI
Actual Study Start Date : July 5, 2018
Estimated Primary Completion Date : May 31, 2022
Estimated Study Completion Date : May 31, 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Cycling Only
Moderate-intensity cycling, 3 times a week for 6 months, supervised by an exercise specialist
Behavioral: Cycling Only
Cycling on a recumbent stationary cycle

Active Comparator: Cognitive Training Only
Computerized cognitive training, 3 times a week for 6 months, supervised by a specialist
Behavioral: Cognitive Training Only
Engage in cognitive training on a computer

Experimental: ACT
Moderate-intensity cycling followed by computerized cognitive training, 3 times a week for 6 months, supervised by a specialist
Behavioral: ACT
ACT stands for combined aerobic exercise and cognitive training.

Sham Comparator: Stretching and Mental Stimulation Activities
Stretching and mental stimulation activities, 3 times a week for 6 months, supervised by a specialist
Behavioral: Stretching and Mental Stimulating Activities
Stretching exercises and mental stimulating activities on a computer




Primary Outcome Measures :
  1. Cognition [ Time Frame: Change from baseline to 3, 6, 12, and 18 months ]
    Change in the composite measures of executive function and episodic memory


Secondary Outcome Measures :
  1. AD-signature cortical thickness [ Time Frame: Change from baseline to 6, 12, and 18 months ]
    measured by the Magnetic Resonance Imaging (MRI)

  2. Functional connectivity [ Time Frame: Change from baseline to 6, 12, and 18 months ]
    measured by functional MRI

  3. Aerobic fitness [ Time Frame: Change from baseline to 3, 6, 12, and 18 months ]
    measured by the symptom-limited peak cycle-ergometer test

  4. Conversion to Alzheimer's diseae [ Time Frame: Change in clinical status from MCI to AD at 6, 12, and 18 months ]
    Change in memory, global cognition, and instrumental activities of daily living will be assessed to make a clinical decision if a participant has progressed from MCI to AD



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • A clinical diagnosis of MCI, Community-dwelling, Age 65 years and older, English-speaking, Adequate visual acuity, Verified exercise safety by medical provider, Stable on drugs affecting cognitive and psychological status, Verified MRI safety, and Capacity to consent.

Exclusion Criteria:

  • Geriatric Depression Scale < 5, Resting heart rate (HR) ≤50 due to arrhythmia or ≥100 beats/min, Neurological (e.g., dementia, head trauma), psychiatric (e.g., bipolar, schizophrenia, or depression), or substance dependency (alcohol or chemical dependency) in the past 5 years that are the main contributor to MCI, Contraindications to exercise, e.g. unstable angina, recent surgery, New symptoms or diseases that have not been evaluated by a health care provider, Current enrollment in another intervention study related to cognitive improvement (reduce confounding effects on outcomes), and Abnormal MRI findings.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03313895


Contacts
Layout table for location contacts
Contact: Fang Yu, PhD 612-624-5435 yuxxx244@umn.edu
Contact: Susan Greimel, MS 612-626-9655 moone104@umn.edu

Locations
Layout table for location information
United States, Minnesota
University of Minnesota Recruiting
Minneapolis, Minnesota, United States, 55455
Contact: Susan Greimel, MS    612-626-9490    moone104@umn.edu   
Contact: Fang Yu, PhD    6126245435    yuxxx244@umn.edu   
Principal Investigator: Fang Yu, PhD         
United States, New York
University of Rochester Recruiting
Rochester, New York, United States, 14642
Contact: Alanna Jacobs, MS    585-276-5802    Alanna_Jacobs@urmc.rochester.edu   
Principal Investigator: Vankee Lin, PhD         
Sponsors and Collaborators
University of Minnesota
University of Rochester
Mayo Clinic
University of St Thomas
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University of Minnesota
ClinicalTrials.gov Identifier: NCT03313895    
Other Study ID Numbers: STUDY00001135
First Posted: October 18, 2017    Key Record Dates
Last Update Posted: October 29, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University of Minnesota:
cognitive impairment, Alzheimer's disease, exercise, cognitive training, imaging
Additional relevant MeSH terms:
Layout table for MeSH terms
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders